Academic Bibliography

Search 200 years of publications by Ghent University researchers.

dr. apr. Rein Verbeke

Faculty of Pharmaceutical Sciences > Department of Pharmaceutics

ORCID iD: 0000-0003-1849-5411

Add to list
- Journal Article
- A1
- open access
Lipid-stabilized ICG nanoaggregates for the photodisruption of vitreous opacities

Pouria Ramezani (UGent) , Jan Félix (UGent) , Yera Ussembayev (UGent) , Mariana Hugo Borges Barreto Silva (UGent) , Ine Lentacker (UGent) , Rein Verbeke (UGent) , Kevin Braeckmans (UGent) , Stefaan De Smedt (UGent) and Félix Sauvage (UGent)

(2026) MATERIALS TODAY BIO. 37.
Add to list
- Journal Article
- A1
- open access
Lipid nanoparticles as a tool to dissect dendritic cell maturation pathways

Sofie Rennen (UGent) , Victor Bosteels, Clint De Nolf (UGent) , Sandra Maréchal (UGent) , Jessica Vetters (UGent) , Karo Van Lil (UGent) , Greta Webb (UGent) , Janne Swinnen (UGent) , Evelien Van De Velde (UGent) , Farzaneh Fayazpour (UGent) , et al.

(2025) CELL REPORTS. 44(8).
Add to list
- Miscellaneous
Lipid-stabilized ICG nanoaggregates for the photodisruption of vitreous opacities

Pouria Ramezani (UGent) , Jan Félix (UGent) , Mariana Hugo Borges Barreto Silva (UGent) , Ine Lentacker (UGent) , Rein Verbeke (UGent) , Kevin Braeckmans (UGent) , Stefaan De Smedt (UGent) and Félix Sauvage (UGent)

(2025) bioRxiv.
Add to list
- Journal Article
- A1
- open access
Immunopeptidomics identified antigens for mRNA-lipid nanoparticle vaccines with alpha-galactosylceramide in multiple myeloma therapy

Arne van der Vreken, Fabien Henri Thery (UGent) , Chenggong Tu, Kevin Mwangi (UGent) , Sofie Meulewaeter (UGent) , Lien De Beck, Edith Janssens, Kim De Veirman, Karin Vanderkerken, Elke De Bruyne, et al.

(2025) JOURNAL FOR IMMUNOTHERAPY OF CANCER. 13(4).
Add to list
- Journal Article
- A1
- open access
Challenges and opportunities in mRNA vaccine development against bacteria

Ilke Aernout (UGent) , Rein Verbeke (UGent) , Fabien Henri Thery (UGent) , Patrick Willems (UGent) , Uri Elia, Stefaan De Smedt (UGent) , Rino Rappuoli, Dan Peer, Francis Impens (UGent) and Ine Lentacker (UGent)

(2025) NATURE MICROBIOLOGY. 10(8). p.1816-1828
Add to list
- Miscellaneous
Lipid nanoparticles as a tool to dissect dendritic cell maturation pathways

Sofie Rennen (UGent) , Victor Bosteels, Clint De Nolf (UGent) , Greta Webb (UGent) , Karo Van Lil (UGent) , Sandra Maréchal (UGent) , Jessica Vetters (UGent) , Evelien Van De Velde (UGent) , Farzaneh Fayazpour (UGent) , Ria Roelandt (UGent) , et al.

(2025)
Add to list
- Journal Article
- A1
- open access
Preclinical toxicological assessment of an α-galactosylceramide-adjuvanted mRNA cancer vaccine in Wistar Han rats and domestic pigs

Sofie Meulewaeter (UGent) , Margo De Velder (UGent) , Diethard Reckelbus (UGent) , Kevin Mwangi (UGent) , Thomas Ehouarne (UGent) , Ilke Aernout (UGent) , Yanou Engelen (UGent) , Fëllanza Halimi (UGent) , Isis Van herteryck (UGent) , Lobke De Bels (UGent) , et al.

(2025) MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT. 33(2).
Add to list
- Journal Article
- A1
- open access
mRNA galsomes vaccine protects budgerigars against virulent Chlamydia psittaci challenge

Anne De Meyst (UGent) , Joeri Van Mieghem, Koen Chiers (UGent) , Koen Raemdonck (UGent) , Rein Verbeke (UGent) , Ine Lentacker (UGent) and Daisy Vanrompay (UGent)

(2025) VACCINES. 13(2).
Add to list
- Book Chapter
Current state of mRNA vaccine development against Mycobacterium tuberculosis

Ilke Aernout (UGent) , Rein Verbeke (UGent) , Stefaan De Smedt (UGent) , Francis Impens (UGent) and Ine Lentacker (UGent)

(2025) Trends in mRNA vaccine research. p.325-335
Add to list
- Book Chapter
A historical overview on mRNA vaccine development

Rein Verbeke (UGent) , Miffy H.Y. Cheng and Pieter C. Cullis

(2025) Trends in mRNA vaccine research. p.1-27

1
2
3
4
5

Next →